Neuropeptide Substance P Improves Osteoblastic and Angiogenic Differentiation Capacity of Bone Marrow Stem Cells<i>In Vitro</i>Su Fu, Dan Jin|BioMed Research International|2014Cited by 56
RETRACTED: The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLCDan Jin, Shuying Tan|EBioMedicine|2018Cited by 52
Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathwayDan Jin, Jiwei Guo|Oncology Reports|2018Cited by 21
Synergistic Effects of Chemotherapy and Phototherapy on Ovarian Cancer Using Follicle-Stimulating Hormone Receptor-Mediated Liposomes Co-Loaded with SN38 and IR820Lina Pian, Mingji Jin, Nuoya Wang et al.|Preprints.org|2024Cited by 1